A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma (mPA)

Introduction: No standard 2nd-line chemotherapy exists for mPA albeit a randomized trial suggested that salvage chemotherapy may improve OS compared to best supportive care.

Saved in:
Bibliographic Details
Published in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2013-05, Vol.13 (3), p.S52-S52
Main Authors: Belli, Carmen, Cereda, Stefano, Balzano, Gianpaolo, Piemonti, Lorenzo, D'Incalci, Maurizio, Allavena, Paola, Miggiano, Chiara, Rognone, Alessia, Fugazza, Clara, Reni, Michele
Format: Article
Language:English
Subjects:
Chemotherapy
Endocrinology & Metabolism
Gastroenterology and Hepatology
Ovarian cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: No standard 2nd-line chemotherapy exists for mPA albeit a randomized trial suggested that salvage chemotherapy may improve OS compared to best supportive care.
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2013.04.178